Initial results from the TRILUMINATE trial show Abbott Laboratories Inc.’s transcatheter tricuspid valve repair (TTVR) system can significantly reduce tricuspid regurgitation and improve heart failure symptoms.
Tricuspid regurgitation, a backward flow of blood from the heart’s right ventricle through the tricuspid valve into the right atrium, can eventually cause right-heart failure. About 3% of people over...